Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supra-scapular nerve block added to standard care for adhesive capsulitis
ACTRN12615001378516Phase 3Completed
- Sponsor
- Flinders University
- Start
- Mar 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bupivacaine and methylprednisolone in adhesive capsulitis (AC) (2 arms), sponsored by Flinders University. Primary endpoint: Range of shoulder motion at 24 months. Started Mar 2016; status: completed.
02
Drugs
bupivacainemethylprednisolone
03
Conditions
adhesive capsulitis (AC)
Beyond the preview
Go deeper on ACTRN12615001378516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001378516.